Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 11, 2015 08:30 ET | Source: MediWound Ltd.

MediWound Approved for First Grant to Support EscharEx(TM) Development Program

YAVNE, Israel, June 11, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company developing, manufacturing and commercializing innovative therapies to...
June 01, 2015 08:00 ET | Source: MediWound Ltd.

MediWound to Present at Jefferies 2015 Global Healthcare Conference

YAVNE, Israel, June 1, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company developing, manufacturing and commercializing innovative therapies to...
May 04, 2015 07:00 ET | Source: MediWound Ltd.

MediWound Reports First Quarter 2015 Financial Results

YAVNE, Israel, May 4, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound...
April 29, 2015 09:47 ET | Source: MediWound Ltd.

Poster Presentation Highlighting NexoBrid(TM) Awarded Best-in-Category in Wound Care Practice at the American Burn Association 47th Annual Meeting

YAVNE, Israel, April 29, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 23, 2015 09:30 ET | Source: MediWound Ltd.

MediWound to Host First Quarter 2015 Financial Results Conference Call on May 4, 2015 at 8:30 a.m.

YAVNE, Israel, April 23, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 21, 2015 08:00 ET | Source: MediWound Ltd.

MediWound's NexoBrid(R) Highlighted in Presentations at the 2015 American Burn Association 47th Annual Meeting

YAVNE, Israel, April 21, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
April 20, 2015 08:00 ET | Source: MediWound Ltd.

MediWound Initiates U.S. Phase 3 Trial With NexoBrid(R) to Treat Severe Burns

YAVNE, Israel, April 20, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management,...
March 23, 2015 09:00 ET | Source: MediWound Ltd.

MediWound's NexoBrid Highlighted in a Presentation at the International Conference on Minimally Invasive Medicine

YAVNE, Israel, March 23, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
February 06, 2015 08:00 ET | Source: MediWound Ltd.

MediWound to Host Fourth Quarter and Year End 2014 Financial Results Conference Call on February 12, 2015 at 8:30 a.m. Eastern Time

YAVNE, Israel, Feb. 6, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...
February 04, 2015 08:00 ET | Source: MediWound Ltd.

MediWound to Ring the NASDAQ Stock Market Closing Bell on February 5, 2015 in Recognition of Burn Awareness Week

YAVNE, Israel, Feb. 4, 2015 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated, biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and...